(PharmaNewsWire.Com, June 13, 2017 ) Market Research HUB, the industry analysis specialist, has released its latest report, “ Germany Healthcare Industry : Healthcare, Regulatory and Reimbursement Landscape 2017 ”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Germany. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by Market Research HUB’s team of industry experts.
In 2016, Germany population was approximately at 82.2 million. The German pharmaceutical market is the largest in Europe and the third largest in the world after the US and Japan. The market value increased from €37.8 billion ($48.6 billion) in 2009 to €52.9 billion ($67.9 billion) in 2016, at a Compound Annual Growth Rate (CAGR) of 4.9%. The market value comprises revenues from drug stores and discount stores, including taxes. The value of the market is expected to reach €67.2 billion ($86.3 billion) in 2021. The medical device market was valued at $21.1 billion in 2009 and increased to $27.5 billion in 2016. It is expected to grow at a CAGR of 4.5% from $28.8 billion in 2017 to $34.4 billion in 2021. These positive trends can primarily be attributed to:
An increasing elderly population in Germany, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare
The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes:
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pfizer) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter International and B.Braun) An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure An overview of the opportunities for and challenges to growth in the German healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to:
Develop business strategies by understanding the trends shaping and driving German healthcare market Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership Identify, understand, and capitalize on the opportunities and challenges in German healthcare market
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of Pharmaceutical Market Research Reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
